Ticker LaunchRegulation A · Tier 2 · AIDX
20/20 Biolabs, Inc.
20/20 Biolabs, Inc. (AIDX) filed a Tier 2 Regulation A offering statement (Form 1-A) on Aug 12, 2019 for up to $14.7M at $4.40 per security. The SEC qualified the offering on Jan 8, 2020. Its securities are listed on Nasdaq under AIDX. Underwriter or broker: S, t and a.
- Status
- Qualified
- Tier
- Tier 2
- Offering size
- $14.7M
- Offer price
- $4.40
- Security type
- Equity (common or preferred stock)
- Filed
- Aug 12, 2019
- Qualified
- Jan 8, 2020
- Ticker
- AIDX
- Exchange
- Nasdaq
- Industry
- Services-Testing Laboratories
- State
- MD
- Underwriter / broker
- S, t, a, r, E, n, g, i, e, P, m, y, L and C
More on this offering for subscribers
- Revenue, net income and total assets from the offering statement
- Employees
- Market cap at the offer price
- Auditor
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Offering statement (Form 1-A) Aug 12, 2019
- Final offering circular (253G2)
- All filings on EDGAR CIK 1139685
Other qualified Business services Reg A offerings
- Grow Solutions Holdings, Inc.Feb 20, 2020 · $3M
- Jet Token Inc.Feb 18, 2020 · $10M
- DNA Brands IncJan 17, 2020 · $2.5M
- Cocannco, Inc.Dec 23, 2019 · $50M
- 1847 Holdings LLCNov 6, 2019 · $8M
- SNM Global HoldingsSep 11, 2019 · $1.6M